Home›Zonisamide›Zonisamide + Metformin

Does Zonisamide Interact with Metformin?

The metformin label names zonisamide among carbonic anhydrase inhibitors. It connects their tendency to lower serum bicarbonate and cause metabolic acidosis with increased lactic-acidosis risk during metformin use.

Label evidence and limitations

Named-drug label evidence. The label recommends considering more frequent monitoring. This supports the warning but is not an FDA assignment of CDI’s major category or a patient-specific risk estimate.

Product scope: Oral metformin hydrochloride film-coated tablets.

Read the DailyMed label: These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE TABLETS. METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1995
Section: 7 Drug Interactions — Carbonic Anhydrase Inhibitors. Compared version 1, label date 2026-10-09. The linked label may be updated after this comparison.

The original record has no saved label identifier. This comparison uses a label located during the source check; it does not recover the original extraction source.

AI-assisted source comparison dated 2026-10-16. This is a comparison of label text, not independent clinical review or an individual safety assessment. CDI's stored severity category is not an FDA-assigned rating. Confirm your exact medicines and formulations with your pharmacist or prescriber before changing treatment.

Stored CDI classification
Major
Zonisamide Class
Anti-epileptic Agent
Management
Confirm exact products with your pharmacist
Data Source
Product label via NLM DailyMed

What To Tell Your Doctor or Pharmacist

If you are taking Zonisamide and your doctor is considering prescribing Metformin (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Zonisamide(Zonisade)+💊 Metformin(Kazano)

Severity & Interaction Details

⚠️
Stored CDI classification: major
Named-drug label evidence
The label recommends considering more frequent monitoring. This supports the warning but is not an FDA assignment of CDI’s major category or a patient-specific risk estimate.
Stored CDI scale
MinorContra
On record
Yes
Drug A class
Anti-epileptic Agent
Drug B class
—
Source
NLP:metformin

How to interpret this source comparison

The label recommends considering more frequent monitoring. This supports the warning but is not an FDA assignment of CDI’s major category or a patient-specific risk estimate.

About Zonisamide and Metformin

Zonisamide is an Anti-epileptic Agent. You may recognize them by the brand names Zonisade and Kazano. Metformin additionally carries an FDA boxed warning, the FDA's strongest safety alert.

Source and Limitations

This record was produced by automated extraction from drug-label information, including AI processing. The summary and mechanism are not verbatim FDA quotations. The drug profiles below may describe different formulations from the source label. Confirm the exact product and route with your pharmacist. This page does not establish independent clinical review.

📖 Source: NLP:metformin

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Zonisamide and Metformin against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
How this information is prepared: CDI uses automated extraction, including AI, to summarize drug labeling from openFDA and includes separately identified curated-reference records. RxNorm helps identify medications; it does not verify interaction claims. Extracted summaries and CDI severity classifications can contain errors and are not verbatim FDA statements or independent clinical review. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.

CDI: source-linked explanations